Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 4.32 USD 1.41% Market Closed
Market Cap: 377.3m USD

Intrinsic Value

TERN's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one TERN stock under the Base Case scenario is 4.1 USD. Compared to the current market price of 4.32 USD, Terns Pharmaceuticals Inc is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TERN Intrinsic Value
4.1 USD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Terns Pharmaceuticals Inc

Compare TERN to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TERN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Terns Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Terns Pharmaceuticals Inc

Current Assets 337.7m
Cash & Short-Term Investments 334.3m
Other Current Assets 3.5m
Non-Current Assets 1.6m
PP&E 1.2m
Other Non-Current Assets 351k
Efficiency

Free Cash Flow Analysis
Terns Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Terns Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-103.9m USD
Operating Income
-103.9m USD
Other Expenses
13.5m USD
Net Income
-90.4m USD
Fundamental Scores

TERN Profitability Score
Profitability Due Diligence

Terns Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
21/100
Profitability
Score

Terns Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

TERN Solvency Score
Solvency Due Diligence

Terns Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Terns Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TERN Price Targets Summary
Terns Pharmaceuticals Inc

Wall Street analysts forecast TERN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TERN is 18.58 USD with a low forecast of 7.58 USD and a high forecast of 35.7 USD.

Lowest
Price Target
7.58 USD
75% Upside
Average
Price Target
18.58 USD
330% Upside
Highest
Price Target
35.7 USD
726% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Terns Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TERN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TERN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TERN stock?

The intrinsic value of one TERN stock under the Base Case scenario is 4.1 USD.

Is TERN stock undervalued or overvalued?

Compared to the current market price of 4.32 USD, Terns Pharmaceuticals Inc is Overvalued by 5%.

Back to Top